Users of this system, can login to view this document.
Login
Enter the following information to request a copy of the document from the responsible person.
Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): a one year period follow up phase 4 study
This email address is used for sending the document.
